Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune ...

Texas Tech University Health Sciences Center's psychiatry program improves mental health care in the Permian Basin, serving ...

Jimmy White, the 62-year-old snooker legend, has opened up about his ADHD diagnosis, saying he wishes he had known about it ...

From patient charts to personal screens, doctors share how they balance screen time at work and home in an increasingly ...

Wedbush started coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) in a research note released on Friday morning, Marketbeat reports. The firm issued an outperform rating and a ...

What is post-vaccination syndrome (PVS), and why is it sparking so much debate? The COVID-19 vaccines have been hailed as a ...

A study by Johns Hopkins Bloomberg School of Public Health researchers found that five minutes a day of light exercise may ...

When considering issues like court-ordered mandatory medication, does society have the right balance between free will and ...

We're everywhere now,” says Debi Ryan, a speech language pathologist. “You can't separate what we do from a student's ...

Akiko Iwasaki, an immunobiologist at Yale and primary author of the study, said the findings are far from a final answer on ...

A Yale University study explores the newly defined post-vaccination syndrome (PVS), revealing alarming biological changes ...

Systemic Scleroderma Treatment Market 2032 The systemic scleroderma treatment market is set to grow from USD 1.34 Bn in 2025 to USD 1.99 Bn ...